Angiotensin-Converting Enzyme Inhibitors
"Angiotensin-Converting Enzyme Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
| Descriptor ID |
D000806
|
| MeSH Number(s) |
D27.505.519.389.745.085
|
| Concept/Terms |
Angiotensin-Converting Enzyme Inhibitors- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitors
- Inhibitors, Kininase II
- Kininase II Antagonists
- Kininase II Inhibitors
- Angiotensin I-Converting Enzyme Inhibitors
- Angiotensin I Converting Enzyme Inhibitors
- Antagonists, Angiotensin-Converting Enzyme
- Antagonists, Angiotensin Converting Enzyme
- Antagonists, Kininase II
- Inhibitors, ACE
- ACE Inhibitors
- Inhibitors, Angiotensin-Converting Enzyme
- Enzyme Inhibitors, Angiotensin-Converting
- Inhibitors, Angiotensin Converting Enzyme
- Angiotensin-Converting Enzyme Antagonists
- Angiotensin Converting Enzyme Antagonists
- Enzyme Antagonists, Angiotensin-Converting
|
Below are MeSH descriptors whose meaning is more general than "Angiotensin-Converting Enzyme Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Angiotensin-Converting Enzyme Inhibitors".
This graph shows the total number of publications written about "Angiotensin-Converting Enzyme Inhibitors" by people in this website by year, and whether "Angiotensin-Converting Enzyme Inhibitors" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 3 | 8 |
| 1996 | 6 | 5 | 11 |
| 1997 | 7 | 3 | 10 |
| 1998 | 4 | 6 | 10 |
| 1999 | 7 | 3 | 10 |
| 2000 | 7 | 5 | 12 |
| 2001 | 13 | 8 | 21 |
| 2002 | 5 | 10 | 15 |
| 2003 | 14 | 13 | 27 |
| 2004 | 15 | 22 | 37 |
| 2005 | 14 | 14 | 28 |
| 2006 | 6 | 11 | 17 |
| 2007 | 10 | 22 | 32 |
| 2008 | 9 | 12 | 21 |
| 2009 | 15 | 19 | 34 |
| 2010 | 10 | 13 | 23 |
| 2011 | 11 | 15 | 26 |
| 2012 | 8 | 8 | 16 |
| 2013 | 13 | 15 | 28 |
| 2014 | 12 | 17 | 29 |
| 2015 | 11 | 8 | 19 |
| 2016 | 14 | 17 | 31 |
| 2017 | 15 | 11 | 26 |
| 2018 | 8 | 9 | 17 |
| 2019 | 13 | 13 | 26 |
| 2020 | 32 | 29 | 61 |
| 2021 | 10 | 21 | 31 |
| 2022 | 2 | 24 | 26 |
| 2023 | 5 | 24 | 29 |
| 2024 | 13 | 11 | 24 |
Below are the most recent publications written about "Angiotensin-Converting Enzyme Inhibitors" by people in Profiles.
-
Medical Histories Associated With Absence of Alzheimer Disease Neuropathologic Changes in the Oldest-Old: The 90+ Study. Neurology. 2025 Jan 14; 104(1):e210107.
-
Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF. J Am Heart Assoc. 2024 Dec 17; 13(24):e036998.
-
Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure. JAMA Cardiol. 2024 Dec 01; 9(12):1154-1158.
-
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial. Circulation. 2024 Nov 26; 150(22):1756-1766.
-
Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial. JAMA. 2024 09 24; 332(12):970-978.
-
Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems. JACC Heart Fail. 2025 Jan; 13(1):43-54.
-
Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2024 Nov; 12(11):1862-1875.
-
Decreased timing to vasospasm prophylaxis improves outcomes among patients with aneurysmal subarachnoid hemorrhage (aSAH) on prehospital CCBs, ARBs, or ACE-inhibitors. J Clin Neurosci. 2024 Sep; 127:110768.
-
Acute changes in kidney function and outcomes following an acute myocardial infarction: Insights from PARADISE-MI. Eur J Heart Fail. 2024 Sep; 26(9):1984-1992.
-
Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes. J Am Heart Assoc. 2024 Aug 06; 13(15):e035177.